Computer-Assisted System for Diagnosis of Alzheimer Disease Using Data Base− Independent Estimation and Fluorodeoxyglucose− Positron-Emission Tomography and 3D-Stereotactic Surface Projection

References

1. 1.↵
   1. Ishii K

   . Clinical application of positron emission tomography for diagnosis of dementia. Ann Nucl Med 2002;16:515–25

   PubMedWeb of Science
2. 2.↵
   1. Herholz K

   . PET studies in dementia. Ann Nucl Med 2003;17:79–89

   PubMedWeb of Science
3. 3.↵
   1. Minoshima S,
   2. Giordani B,
   3. Berent S,
   4. et al

   . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85–94

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Minoshima S,
   2. Frey KA,
   3. Foster NL,
   4. et al

   . Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995;19:541–47

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ishii K,
   2. Sasaki M,
   3. Kitagaki H,
   4. et al

   . Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997;38:925–28

   Abstract/FREE Full Text
6. 6.↵
   1. Burdette JH,
   2. Minoshima S,
   3. Vander Borght T,
   4. et al

   . Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996;198:837–43

   PubMedWeb of Science
7. 7.↵
   1. Herholz K,
   2. Salmon E,
   3. Perani D,
   4. et al

   . Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302–16

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Ishii K,
   2. Kono AK,
   3. Sasaki H,
   4. et al

   . Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP. Eur J Nucl Med Mol Imaging 2006;33:575–83

   CrossRefPubMed
9. 9.↵
   1. Fan Y,
   2. Resnick SM,
   3. Wu X,
   4. et al

   . Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 2008;41:277–85

   CrossRefPubMedWeb of Science
10. 10.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

    Abstract/FREE Full Text
11. 11.↵
    1. Minoshima S,
    2. Frey KA,
    3. Koeppe RA,
    4. et al

    . A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238–48

    Abstract/FREE Full Text
12. 12.↵
    1. Chen WP,
    2. Samuraki M,
    3. Yanase D,
    4. et al

    . Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis. Nucl Med Commun 2008;29:270–76

    CrossRefPubMed
13. 13.↵
    1. Yakushev I,
    2. Landvogt C,
    3. Buchholz HG,
    4. et al

    . Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 2008;164:143–53

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Kono AK,
    2. Ishii K,
    3. Sofue K,
    4. et al

    . Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. Eur J Nucl Med Mol Imaging 2007;34:1490–97

    CrossRefPubMedWeb of Science